Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT111 | Cell Line | K562 | Homo sapiens | GI50 | 16982.44 | nM | 20061160 | |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | 14288.94 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Activity | = | 80.4 | % | 10514324 | |
NPT403 | Cell Line | UACC-257 | Homo sapiens | GI50 | 28379.19 | nM | 25927586 | |
NPT393 | Cell Line | HCT-116 | Homo sapiens | GI50 | 18113.4 | nM | 24582402 | |
NPT406 | Cell Line | RXF 393 | Homo sapiens | GI50 | 6295.06 | nM | 17850214 | |
NPT372 | Cell Line | HOP-92 | Homo sapiens | GI50 | 19633.6 | nM | 9548847 | |
NPT147 | Cell Line | SK-MEL-2 | Homo sapiens | GI50 | 17179.08 | nM | 10869203 | |
NPT400 | Cell Line | MDA-MB-435 | Homo sapiens | GI50 | 18749.95 | nM | 24144848 | |
NPT148 | Cell Line | HCT-15 | Homo sapiens | GI50 | 11614.49 | nM | 16933872 | |
NPT394 | Cell Line | EKVX | Homo sapiens | GI50 | 26121.61 | nM | Open TG-GATES in vivo data: Biochemistry | |
NPT308 | Cell Line | CAKI-1 | Homo sapiens | GI50 | 17139.57 | nM | Open TG-GATES in vivo data: Biochemistry | |
NPT385 | Cell Line | SR | Homo sapiens | GI50 | 4497.8 | nM | Open TG-GATES in vivo data: Organ Weight | |
NPT368 | Cell Line | SN12C | Homo sapiens | GI50 | 16443.72 | nM | 23571415 | |
NPT139 | Cell Line | HT-29 | Homo sapiens | GI50 | 4345.1 | nM | 4851320 | |
NPT323 | Cell Line | SW-620 | Homo sapiens | GI50 | 24322.04 | nM | 10.6019/CHEMBL1201861 | |
NPT458 | Cell Line | IGROV-1 | Homo sapiens | GI50 | 20323.57 | nM | 26149591 | |
NPT374 | Cell Line | SF-539 | Homo sapiens | GI50 | 18113.4 | nM | 20014752 | |
NPT395 | Cell Line | SF-268 | Homo sapiens | GI50 | 17418.07 | nM | DrugMatrix in vivo data: Pathology | |
NPT398 | Cell Line | UACC-62 | Homo sapiens | GI50 | 19952.62 | nM | 8786361 | |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | GI50 | 22130.95 | nM | 16933872 | |
NPT378 | Cell Line | NCI/ADR-RES | Homo sapiens | GI50 | 26977.39 | nM | 17067151 | |
NPT370 | Cell Line | NCI-H23 | Homo sapiens | GI50 | 17579.24 | nM | 25970729 | |
NPT388 | Cell Line | NCI-H322M | Homo sapiens | GI50 | 19453.6 | nM | 17685651 | |
NPT407 | Cell Line | COLO 205 | Homo sapiens | GI50 | 9246.98 | nM | 8496911 | |
NPT373 | Cell Line | SK-MEL-5 | Homo sapiens | GI50 | 18323.14 | nM | 20038128 | |
NPT382 | Cell Line | OVCAR-5 | Homo sapiens | GI50 | 100000 | nM | 20430633 | |
NPT2 | Others | Unspecified | Activity | = | 61.8 | % | 18760601 | |
NPT2 | Others | Unspecified | Activity | = | 46.8 | % | 18760601 | |
NPT376 | Cell Line | A498 | Homo sapiens | GI50 | 22080.05 | nM | PubChem BioAssay data set | |
NPT116 | Cell Line | HL-60 | Homo sapiens | GI50 | 10423.17 | nM | 18578517 | |
NPT306 | Cell Line | PC-3 | Homo sapiens | GI50 | 12912.19 | nM | 10978206 | |
NPT405 | Cell Line | NCI-H226 | Homo sapiens | GI50 | 12161.86 | nM | 8691203 | |
NPT380 | Cell Line | U-251 | Homo sapiens | GI50 | 17100.15 | nM | 15165148 | |
NPT381 | Cell Line | OVCAR-8 | Homo sapiens | GI50 | 16865.53 | nM | 20439614 | |
NPT387 | Cell Line | M14 | Homo sapiens | GI50 | 13803.84 | nM | 18725441 | |
NPT456 | Cell Line | OVCAR-4 | Homo sapiens | GI50 | 13091.82 | nM | 10.1007/s00044-007-9020-0 | |
NPT81 | Cell Line | A549 | Homo sapiens | GI50 | 14223.29 | nM | 21524588 | |
NPT170 | Cell Line | SK-MEL-28 | Homo sapiens | GI50 | 29107.17 | nM | 18077363 | |
NPT367 | Cell Line | MDA-N | Homo sapiens | GI50 | 19319.68 | nM | DrugMatrix in vivo data: Biochemistry | |
NPT384 | Cell Line | TK-10 | Homo sapiens | GI50 | 27669.42 | nM | 20585132 | |
NPT401 | Cell Line | 786-0 | Homo sapiens | GI50 | 26607.25 | nM | 18088097 | |
NPT390 | Cell Line | LOX IMVI | Homo sapiens | GI50 | 11939.88 | nM | 23806110 | |
NPT402 | Cell Line | Hs-578T | Homo sapiens | GI50 | 28444.61 | nM | 19848433 | |
NPT386 | Cell Line | KM12 | Homo sapiens | GI50 | 6123.5 | nM | 22445674 | |
NPT83 | Cell Line | MCF7 | Homo sapiens | GI50 | 20276.83 | nM | 20073490 | |
NPT371 | Cell Line | UO-31 | Homo sapiens | GI50 | 17906.06 | nM | 23237411 | |
NPT392 | Cell Line | SNB-75 | Homo sapiens | GI50 | 20749.14 | nM | 8496706 | |
NPT2 | Others | Unspecified | Activity | = | 59.8 | % | 25819096 | |
NPT112 | Cell Line | MOLT-4 | Homo sapiens | GI50 | 8933.05 | nM | 20151678 | |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | GI50 | 15417 | nM | 18838598 | |
NPT455 | Cell Line | NCI-H522 | Homo sapiens | GI50 | 15958.79 | nM | 18490506 | |
NPT389 | Cell Line | RPMI-8226 | Homo sapiens | GI50 | 20323.57 | nM | 10.1007/s00044-011-9628-y | |
NPT375 | Cell Line | Malme-3M | Homo sapiens | GI50 | 16330.52 | nM | 24927053 | |
NPT383 | Cell Line | SNB-19 | Homo sapiens | GI50 | 18323.14 | nM | 24095094 | |
NPT369 | Cell Line | ACHN | Homo sapiens | GI50 | 16255.49 | nM | 24095094 | |
NPT90 | Cell Line | DU-145 | Homo sapiens | GI50 | 30199.52 | nM | 8864236 | |
NPT399 | Cell Line | SF-295 | Homo sapiens | GI50 | 12912.19 | nM | 23354072 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC241100 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC159275 |
0.9926 | High Similarity | NPC282300 |
0.9926 | High Similarity | NPC110969 |
0.9925 | High Similarity | NPC220062 |
0.9925 | High Similarity | NPC78913 |
0.9925 | High Similarity | NPC216978 |
0.9925 | High Similarity | NPC55018 |
0.9925 | High Similarity | NPC301217 |
0.9925 | High Similarity | NPC18260 |
0.9925 | High Similarity | NPC303633 |
0.9925 | High Similarity | NPC96565 |
0.9925 | High Similarity | NPC53181 |
0.9925 | High Similarity | NPC217186 |
0.9853 | High Similarity | NPC11561 |
0.9853 | High Similarity | NPC226636 |
0.9852 | High Similarity | NPC150522 |
0.9852 | High Similarity | NPC172986 |
0.9852 | High Similarity | NPC261227 |
0.9852 | High Similarity | NPC270883 |
0.9851 | High Similarity | NPC201395 |
0.9779 | High Similarity | NPC118840 |
0.9779 | High Similarity | NPC64908 |
0.9779 | High Similarity | NPC147688 |
0.9779 | High Similarity | NPC103362 |
0.9779 | High Similarity | NPC205006 |
0.9779 | High Similarity | NPC156590 |
0.971 | High Similarity | NPC216538 |
0.971 | High Similarity | NPC234629 |
0.971 | High Similarity | NPC319752 |
0.971 | High Similarity | NPC311741 |
0.971 | High Similarity | NPC273538 |
0.9708 | High Similarity | NPC217083 |
0.9708 | High Similarity | NPC62840 |
0.9708 | High Similarity | NPC200694 |
0.9708 | High Similarity | NPC306829 |
0.9708 | High Similarity | NPC265040 |
0.9708 | High Similarity | NPC78803 |
0.9708 | High Similarity | NPC10937 |
0.9708 | High Similarity | NPC324436 |
0.9708 | High Similarity | NPC125855 |
0.9708 | High Similarity | NPC167624 |
0.9708 | High Similarity | NPC76372 |
0.9708 | High Similarity | NPC78 |
0.9708 | High Similarity | NPC66515 |
0.9708 | High Similarity | NPC166482 |
0.9708 | High Similarity | NPC37496 |
0.9708 | High Similarity | NPC227579 |
0.9708 | High Similarity | NPC214236 |
0.9708 | High Similarity | NPC64915 |
0.9708 | High Similarity | NPC223500 |
0.9708 | High Similarity | NPC328164 |
0.9708 | High Similarity | NPC40833 |
0.9708 | High Similarity | NPC324134 |
0.9708 | High Similarity | NPC1089 |
0.9708 | High Similarity | NPC299080 |
0.9708 | High Similarity | NPC161506 |
0.9708 | High Similarity | NPC59739 |
0.9708 | High Similarity | NPC296917 |
0.9708 | High Similarity | NPC220998 |
0.9708 | High Similarity | NPC194432 |
0.9708 | High Similarity | NPC182852 |
0.9708 | High Similarity | NPC166934 |
0.9708 | High Similarity | NPC177354 |
0.9708 | High Similarity | NPC32739 |
0.9708 | High Similarity | NPC293852 |
0.9708 | High Similarity | NPC148757 |
0.9708 | High Similarity | NPC76338 |
0.9708 | High Similarity | NPC228504 |
0.9708 | High Similarity | NPC107572 |
0.9706 | High Similarity | NPC235239 |
0.9706 | High Similarity | NPC475680 |
0.9706 | High Similarity | NPC305355 |
0.9706 | High Similarity | NPC69769 |
0.9701 | High Similarity | NPC234133 |
0.9701 | High Similarity | NPC194281 |
0.9701 | High Similarity | NPC174999 |
0.9701 | High Similarity | NPC13408 |
0.9701 | High Similarity | NPC47815 |
0.9701 | High Similarity | NPC127447 |
0.9701 | High Similarity | NPC29353 |
0.9701 | High Similarity | NPC473887 |
0.9701 | High Similarity | NPC124784 |
0.9701 | High Similarity | NPC231772 |
0.964 | High Similarity | NPC124729 |
0.964 | High Similarity | NPC111786 |
0.964 | High Similarity | NPC470647 |
0.964 | High Similarity | NPC142405 |
0.964 | High Similarity | NPC474161 |
0.964 | High Similarity | NPC246948 |
0.964 | High Similarity | NPC476088 |
0.964 | High Similarity | NPC83357 |
0.964 | High Similarity | NPC178343 |
0.964 | High Similarity | NPC67805 |
0.964 | High Similarity | NPC54577 |
0.964 | High Similarity | NPC301276 |
0.964 | High Similarity | NPC312973 |
0.964 | High Similarity | NPC20488 |
0.964 | High Similarity | NPC214774 |
0.964 | High Similarity | NPC195621 |
0.964 | High Similarity | NPC5820 |
0.964 | High Similarity | NPC267375 |
0.964 | High Similarity | NPC88964 |
0.964 | High Similarity | NPC475052 |
0.964 | High Similarity | NPC176229 |
0.964 | High Similarity | NPC306488 |
0.9638 | High Similarity | NPC316816 |
0.9638 | High Similarity | NPC38219 |
0.9638 | High Similarity | NPC11700 |
0.9638 | High Similarity | NPC478086 |
0.9638 | High Similarity | NPC293053 |
0.9638 | High Similarity | NPC214166 |
0.9638 | High Similarity | NPC77794 |
0.9638 | High Similarity | NPC149026 |
0.9638 | High Similarity | NPC81697 |
0.9638 | High Similarity | NPC91560 |
0.9638 | High Similarity | NPC278249 |
0.9638 | High Similarity | NPC68104 |
0.9638 | High Similarity | NPC257097 |
0.9638 | High Similarity | NPC175504 |
0.9638 | High Similarity | NPC85162 |
0.9638 | High Similarity | NPC18585 |
0.9638 | High Similarity | NPC223812 |
0.9638 | High Similarity | NPC125894 |
0.9638 | High Similarity | NPC158874 |
0.9638 | High Similarity | NPC39329 |
0.9638 | High Similarity | NPC107177 |
0.9638 | High Similarity | NPC221432 |
0.9638 | High Similarity | NPC150408 |
0.9638 | High Similarity | NPC143896 |
0.9638 | High Similarity | NPC169591 |
0.9638 | High Similarity | NPC166138 |
0.9638 | High Similarity | NPC310130 |
0.9638 | High Similarity | NPC75049 |
0.9638 | High Similarity | NPC9117 |
0.9638 | High Similarity | NPC106985 |
0.9638 | High Similarity | NPC219915 |
0.9638 | High Similarity | NPC185276 |
0.9638 | High Similarity | NPC190637 |
0.9638 | High Similarity | NPC164980 |
0.9638 | High Similarity | NPC212932 |
0.9638 | High Similarity | NPC24821 |
0.9635 | High Similarity | NPC96408 |
0.9635 | High Similarity | NPC279650 |
0.9635 | High Similarity | NPC17170 |
0.9635 | High Similarity | NPC3188 |
0.9635 | High Similarity | NPC156190 |
0.9635 | High Similarity | NPC213322 |
0.9635 | High Similarity | NPC324386 |
0.9635 | High Similarity | NPC166689 |
0.9635 | High Similarity | NPC110038 |
0.9635 | High Similarity | NPC4743 |
0.9635 | High Similarity | NPC248372 |
0.9635 | High Similarity | NPC14871 |
0.9635 | High Similarity | NPC258630 |
0.9635 | High Similarity | NPC312391 |
0.9632 | High Similarity | NPC23257 |
0.963 | High Similarity | NPC266597 |
0.963 | High Similarity | NPC250266 |
0.9627 | High Similarity | NPC13575 |
0.9571 | High Similarity | NPC473077 |
0.9571 | High Similarity | NPC104406 |
0.9571 | High Similarity | NPC79469 |
0.9571 | High Similarity | NPC237635 |
0.9571 | High Similarity | NPC23728 |
0.9571 | High Similarity | NPC283234 |
0.9571 | High Similarity | NPC24673 |
0.9571 | High Similarity | NPC201731 |
0.9571 | High Similarity | NPC110303 |
0.9571 | High Similarity | NPC296998 |
0.9571 | High Similarity | NPC97716 |
0.9568 | High Similarity | NPC473015 |
0.9568 | High Similarity | NPC131579 |
0.9568 | High Similarity | NPC236766 |
0.9568 | High Similarity | NPC473014 |
0.9568 | High Similarity | NPC469953 |
0.9568 | High Similarity | NPC224714 |
0.9568 | High Similarity | NPC197252 |
0.9568 | High Similarity | NPC235217 |
0.9568 | High Similarity | NPC209040 |
0.9568 | High Similarity | NPC271288 |
0.9568 | High Similarity | NPC131568 |
0.9568 | High Similarity | NPC326500 |
0.9568 | High Similarity | NPC473013 |
0.9565 | High Similarity | NPC36181 |
0.9565 | High Similarity | NPC144499 |
0.9565 | High Similarity | NPC266725 |
0.9565 | High Similarity | NPC473042 |
0.9562 | High Similarity | NPC129853 |
0.9562 | High Similarity | NPC471587 |
0.9562 | High Similarity | NPC284550 |
0.9562 | High Similarity | NPC219917 |
0.9562 | High Similarity | NPC213659 |
0.9562 | High Similarity | NPC144118 |
0.9562 | High Similarity | NPC80962 |
0.9562 | High Similarity | NPC110228 |
0.9562 | High Similarity | NPC76445 |
0.9562 | High Similarity | NPC259166 |
0.9562 | High Similarity | NPC215311 |
0.9562 | High Similarity | NPC204985 |
0.9562 | High Similarity | NPC172250 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC241100 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.971 | High Similarity | NPD4378 | Clinical (unspecified phase) |
0.9429 | High Similarity | NPD7410 | Clinical (unspecified phase) |
0.9343 | High Similarity | NPD1552 | Clinical (unspecified phase) |
0.9343 | High Similarity | NPD1550 | Clinical (unspecified phase) |
0.9275 | High Similarity | NPD1549 | Phase 2 |
0.9197 | High Similarity | NPD1510 | Phase 2 |
0.9185 | High Similarity | NPD1240 | Approved |
0.913 | High Similarity | NPD2796 | Approved |
0.9051 | High Similarity | NPD1607 | Approved |
0.9048 | High Similarity | NPD2393 | Clinical (unspecified phase) |
0.9041 | High Similarity | NPD7411 | Suspended |
0.8986 | High Similarity | NPD8443 | Clinical (unspecified phase) |
0.8973 | High Similarity | NPD4380 | Phase 2 |
0.8867 | High Similarity | NPD7075 | Discontinued |
0.8851 | High Similarity | NPD6801 | Discontinued |
0.8819 | High Similarity | NPD1511 | Approved |
0.8792 | High Similarity | NPD7819 | Suspended |
0.8792 | High Similarity | NPD2801 | Approved |
0.8792 | High Similarity | NPD7096 | Clinical (unspecified phase) |
0.8725 | High Similarity | NPD1934 | Approved |
0.8699 | High Similarity | NPD1512 | Approved |
0.869 | High Similarity | NPD6799 | Approved |
0.8671 | High Similarity | NPD7421 | Clinical (unspecified phase) |
0.8618 | High Similarity | NPD4381 | Clinical (unspecified phase) |
0.8611 | High Similarity | NPD3750 | Approved |
0.8553 | High Similarity | NPD7768 | Phase 2 |
0.8542 | High Similarity | NPD2800 | Approved |
0.8526 | High Similarity | NPD7852 | Clinical (unspecified phase) |
0.8511 | High Similarity | NPD6651 | Approved |
0.8489 | Intermediate Similarity | NPD6859 | Clinical (unspecified phase) |
0.8481 | Intermediate Similarity | NPD7804 | Clinical (unspecified phase) |
0.8472 | Intermediate Similarity | NPD970 | Clinical (unspecified phase) |
0.8467 | Intermediate Similarity | NPD6599 | Discontinued |
0.8452 | Intermediate Similarity | NPD6959 | Discontinued |
0.8431 | Intermediate Similarity | NPD3882 | Suspended |
0.8414 | Intermediate Similarity | NPD1243 | Approved |
0.8366 | Intermediate Similarity | NPD3817 | Phase 2 |
0.8333 | Intermediate Similarity | NPD1551 | Phase 2 |
0.8333 | Intermediate Similarity | NPD2935 | Discontinued |
0.8291 | Intermediate Similarity | NPD6166 | Phase 2 |
0.8291 | Intermediate Similarity | NPD6168 | Clinical (unspecified phase) |
0.8291 | Intermediate Similarity | NPD6167 | Clinical (unspecified phase) |
0.8272 | Intermediate Similarity | NPD4419 | Clinical (unspecified phase) |
0.8267 | Intermediate Similarity | NPD920 | Approved |
0.8267 | Intermediate Similarity | NPD5403 | Approved |
0.8264 | Intermediate Similarity | NPD3748 | Approved |
0.8264 | Intermediate Similarity | NPD2799 | Discontinued |
0.8258 | Intermediate Similarity | NPD3749 | Approved |
0.8243 | Intermediate Similarity | NPD643 | Clinical (unspecified phase) |
0.8227 | Intermediate Similarity | NPD2313 | Discontinued |
0.8187 | Intermediate Similarity | NPD3818 | Discontinued |
0.8165 | Intermediate Similarity | NPD6232 | Discontinued |
0.8153 | Intermediate Similarity | NPD5494 | Approved |
0.8151 | Intermediate Similarity | NPD2344 | Approved |
0.8148 | Intermediate Similarity | NPD5953 | Discontinued |
0.8137 | Intermediate Similarity | NPD7054 | Approved |
0.8137 | Intermediate Similarity | NPD7286 | Phase 2 |
0.8133 | Intermediate Similarity | NPD2534 | Approved |
0.8133 | Intermediate Similarity | NPD642 | Clinical (unspecified phase) |
0.8133 | Intermediate Similarity | NPD2533 | Approved |
0.8133 | Intermediate Similarity | NPD5401 | Approved |
0.8133 | Intermediate Similarity | NPD2532 | Approved |
0.8129 | Intermediate Similarity | NPD1203 | Approved |
0.8125 | Intermediate Similarity | NPD7473 | Discontinued |
0.8108 | Intermediate Similarity | NPD1878 | Clinical (unspecified phase) |
0.8099 | Intermediate Similarity | NPD4907 | Clinical (unspecified phase) |
0.8099 | Intermediate Similarity | NPD3268 | Approved |
0.8086 | Intermediate Similarity | NPD7472 | Approved |
0.8086 | Intermediate Similarity | NPD7074 | Phase 3 |
0.8074 | Intermediate Similarity | NPD1548 | Phase 1 |
0.8037 | Intermediate Similarity | NPD6797 | Phase 2 |
0.8014 | Intermediate Similarity | NPD7033 | Discontinued |
0.8014 | Intermediate Similarity | NPD1509 | Clinical (unspecified phase) |
0.8 | Intermediate Similarity | NPD2797 | Approved |
0.7988 | Intermediate Similarity | NPD6559 | Discontinued |
0.7988 | Intermediate Similarity | NPD7251 | Discontinued |
0.7971 | Intermediate Similarity | NPD422 | Phase 1 |
0.7971 | Intermediate Similarity | NPD1547 | Clinical (unspecified phase) |
0.7962 | Intermediate Similarity | NPD4868 | Clinical (unspecified phase) |
0.7959 | Intermediate Similarity | NPD6100 | Approved |
0.7959 | Intermediate Similarity | NPD6099 | Approved |
0.7958 | Intermediate Similarity | NPD6832 | Phase 2 |
0.7958 | Intermediate Similarity | NPD4908 | Phase 1 |
0.7943 | Intermediate Similarity | NPD2798 | Approved |
0.7939 | Intermediate Similarity | NPD7808 | Phase 3 |
0.7933 | Intermediate Similarity | NPD2309 | Approved |
0.7922 | Intermediate Similarity | NPD3226 | Approved |
0.7914 | Intermediate Similarity | NPD9717 | Approved |
0.7898 | Intermediate Similarity | NPD5402 | Approved |
0.7867 | Intermediate Similarity | NPD4628 | Phase 3 |
0.7862 | Intermediate Similarity | NPD943 | Approved |
0.7862 | Intermediate Similarity | NPD919 | Approved |
0.7842 | Intermediate Similarity | NPD1610 | Phase 2 |
0.7831 | Intermediate Similarity | NPD4338 | Clinical (unspecified phase) |
0.7829 | Intermediate Similarity | NPD7390 | Discontinued |
0.7808 | Intermediate Similarity | NPD5124 | Phase 1 |
0.7808 | Intermediate Similarity | NPD5123 | Clinical (unspecified phase) |
0.7805 | Intermediate Similarity | NPD5844 | Phase 1 |
0.7801 | Intermediate Similarity | NPD3225 | Approved |
0.78 | Intermediate Similarity | NPD2654 | Approved |
0.7791 | Intermediate Similarity | NPD4363 | Phase 3 |
0.7791 | Intermediate Similarity | NPD4360 | Phase 2 |
0.7785 | Intermediate Similarity | NPD2346 | Discontinued |
0.777 | Intermediate Similarity | NPD4308 | Phase 3 |
0.7764 | Intermediate Similarity | NPD1247 | Approved |
0.7748 | Intermediate Similarity | NPD6398 | Clinical (unspecified phase) |
0.7746 | Intermediate Similarity | NPD3266 | Approved |
0.7746 | Intermediate Similarity | NPD3267 | Approved |
0.7746 | Intermediate Similarity | NPD4361 | Phase 2 |
0.7746 | Intermediate Similarity | NPD4362 | Clinical (unspecified phase) |
0.7707 | Intermediate Similarity | NPD7615 | Clinical (unspecified phase) |
0.7701 | Intermediate Similarity | NPD8090 | Clinical (unspecified phase) |
0.7669 | Intermediate Similarity | NPD3926 | Phase 2 |
0.766 | Intermediate Similarity | NPD3972 | Approved |
0.7655 | Intermediate Similarity | NPD4625 | Phase 3 |
0.7651 | Intermediate Similarity | NPD1729 | Discontinued |
0.7603 | Intermediate Similarity | NPD1296 | Phase 2 |
0.7568 | Intermediate Similarity | NPD1933 | Approved |
0.7564 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.7562 | Intermediate Similarity | NPD4288 | Approved |
0.7554 | Intermediate Similarity | NPD9545 | Approved |
0.7536 | Intermediate Similarity | NPD9493 | Approved |
0.7535 | Intermediate Similarity | NPD1608 | Approved |
0.75 | Intermediate Similarity | NPD1465 | Phase 2 |
0.75 | Intermediate Similarity | NPD7993 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD5711 | Approved |
0.75 | Intermediate Similarity | NPD4307 | Phase 2 |
0.75 | Intermediate Similarity | NPD5710 | Approved |
0.7484 | Intermediate Similarity | NPD5890 | Approved |
0.7484 | Intermediate Similarity | NPD5889 | Approved |
0.7483 | Intermediate Similarity | NPD6798 | Discontinued |
0.7468 | Intermediate Similarity | NPD7458 | Discontinued |
0.7466 | Intermediate Similarity | NPD1529 | Clinical (unspecified phase) |
0.7465 | Intermediate Similarity | NPD1201 | Approved |
0.745 | Intermediate Similarity | NPD1899 | Clinical (unspecified phase) |
0.7445 | Intermediate Similarity | NPD1241 | Discontinued |
0.7436 | Intermediate Similarity | NPD7004 | Clinical (unspecified phase) |
0.7421 | Intermediate Similarity | NPD6585 | Discontinued |
0.7403 | Intermediate Similarity | NPD7003 | Approved |
0.7397 | Intermediate Similarity | NPD1530 | Clinical (unspecified phase) |
0.7394 | Intermediate Similarity | NPD7229 | Phase 3 |
0.7383 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.7383 | Intermediate Similarity | NPD1613 | Approved |
0.7379 | Intermediate Similarity | NPD1470 | Approved |
0.7379 | Intermediate Similarity | NPD1164 | Approved |
0.7374 | Intermediate Similarity | NPD7501 | Clinical (unspecified phase) |
0.7372 | Intermediate Similarity | NPD6143 | Clinical (unspecified phase) |
0.7368 | Intermediate Similarity | NPD5408 | Approved |
0.7368 | Intermediate Similarity | NPD5404 | Approved |
0.7368 | Intermediate Similarity | NPD5405 | Approved |
0.7368 | Intermediate Similarity | NPD5406 | Approved |
0.7365 | Intermediate Similarity | NPD3764 | Approved |
0.7365 | Intermediate Similarity | NPD411 | Approved |
0.7361 | Intermediate Similarity | NPD4749 | Approved |
0.7358 | Intermediate Similarity | NPD5808 | Clinical (unspecified phase) |
0.7353 | Intermediate Similarity | NPD6104 | Discontinued |
0.7346 | Intermediate Similarity | NPD2296 | Approved |
0.7333 | Intermediate Similarity | NPD447 | Suspended |
0.7333 | Intermediate Similarity | NPD230 | Phase 1 |
0.7329 | Intermediate Similarity | NPD1019 | Discontinued |
0.7324 | Intermediate Similarity | NPD17 | Approved |
0.7322 | Intermediate Similarity | NPD7584 | Approved |
0.732 | Intermediate Similarity | NPD2343 | Clinical (unspecified phase) |
0.732 | Intermediate Similarity | NPD1471 | Phase 3 |
0.7305 | Intermediate Similarity | NPD7784 | Clinical (unspecified phase) |
0.7292 | Intermediate Similarity | NPD1481 | Phase 2 |
0.7278 | Intermediate Similarity | NPD5049 | Phase 3 |
0.7273 | Intermediate Similarity | NPD7879 | Clinical (unspecified phase) |
0.7261 | Intermediate Similarity | NPD7213 | Phase 3 |
0.7261 | Intermediate Similarity | NPD7212 | Phase 2 |
0.7257 | Intermediate Similarity | NPD4287 | Approved |
0.7255 | Intermediate Similarity | NPD4476 | Approved |
0.7255 | Intermediate Similarity | NPD4477 | Approved |
0.7254 | Intermediate Similarity | NPD4196 | Clinical (unspecified phase) |
0.7248 | Intermediate Similarity | NPD6410 | Clinical (unspecified phase) |
0.7244 | Intermediate Similarity | NPD2354 | Approved |
0.723 | Intermediate Similarity | NPD1008 | Clinical (unspecified phase) |
0.7229 | Intermediate Similarity | NPD7199 | Phase 2 |
0.7226 | Intermediate Similarity | NPD1652 | Phase 2 |
0.7222 | Intermediate Similarity | NPD6844 | Discontinued |
0.7222 | Intermediate Similarity | NPD1535 | Discovery |
0.7219 | Intermediate Similarity | NPD6355 | Discontinued |
0.7219 | Intermediate Similarity | NPD7893 | Clinical (unspecified phase) |
0.7219 | Intermediate Similarity | NPD5940 | Clinical (unspecified phase) |
0.7215 | Intermediate Similarity | NPD4662 | Approved |
0.7215 | Intermediate Similarity | NPD4661 | Approved |
0.7215 | Intermediate Similarity | NPD7447 | Phase 1 |
0.7202 | Intermediate Similarity | NPD2403 | Approved |
0.72 | Intermediate Similarity | NPD6233 | Phase 2 |
0.7192 | Intermediate Similarity | NPD1876 | Approved |
0.719 | Intermediate Similarity | NPD651 | Clinical (unspecified phase) |
0.7183 | Intermediate Similarity | NPD1894 | Discontinued |
0.7181 | Intermediate Similarity | NPD3027 | Phase 3 |
0.7168 | Intermediate Similarity | NPD8312 | Approved |
0.7168 | Intermediate Similarity | NPD8313 | Approved |
0.7162 | Intermediate Similarity | NPD2861 | Phase 2 |
0.7161 | Intermediate Similarity | NPD2424 | Discontinued |
0.7152 | Intermediate Similarity | NPD4060 | Phase 1 |
0.7152 | Intermediate Similarity | NPD3140 | Approved |
0.7152 | Intermediate Similarity | NPD6971 | Discontinued |
PubChem CID   | 390520 |
ChEMBL   | CHEMBL463111 |
ZINC   |
Molecular Weight:   | 368.13 |
ALogP:   | -0.0589 |
MLogP:   | 3.11 |
XLogP:   | 2.593 |
# Rotatable Bonds:   | 10 |
Polar Surface Area:   | 96.22 |
# H-Bond Aceptor:   | 1 |
# H-Bond Donor:   | 3 |
# Rings:   | 3 |
# Heavy Atoms:   | 27 |